$2.45+Billion Neurorehabilitation Market Size to Grow at 8.35% CAGR Year : 2022 - 30

Allied Market Research recently published a report, titled, "Neurorehabilitation Market by Type (Neuro-Robotic Devices, Non-Invasive Stimulators, and Brain-Computer Interfaces), Application (Brain Stroke, Parkinson's Disease, Multiple Sclerosis, Spinal Cord Injury, Traumatic Brain Injury, Cerebral Palsy, and Others), and End-User (Rehabilitation Centers, Hospitals, and Clinics): Global Opportunity Analysis and Industry Forecast, 2021-2030". As per the report, the global neurorehabilitation market size was accounted for $1.09 billion in 2020, and is anticipated to garner $2.45 billion by 2030, growing at a CAGR of 8.35% from 2021 to 2030.

Growth in prevalence of neurological disorders such as brain stroke, Parkinson's disease, multiple sclerosis, cerebral palsy, traumatic brain injury, spinal cord injury, and rise in awareness about neurorehabilitation devices among population are some factors which drive growth of the neurorehabilitation market. In addition, increase in funding for R&D, and rise in product approvals of neurorehabilitation devices by regulatory authorities further boost growth of the neurorehabilitation market.

𝐆𝐞𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐚𝐭 : https://www.alliedmarketresearch.com/request-sample/10826

𝐌𝐚𝐣𝐨𝐫 𝐦𝐚𝐫𝐤𝐞𝐭 𝐩𝐥𝐚𝐲𝐞𝐫𝐬

Bionik Laboratories Corp.
Bioventus (Bioness Inc.)
BioScience Managers Ltd (Rex Bionics Ltd)
Ekso Bionics Holdings, Inc.
DIH (Hocoma AG)
Neofect
Eodyne
Reha Technology AG
Neuro Rehab VR
ReWalk Robotics Ltd.

𝐃𝐨 𝐘𝐨𝐮 𝐇𝐚𝐯𝐞 𝐀𝐧𝐲 𝐐𝐮𝐞𝐫𝐲 𝐎𝐫 𝐒𝐩𝐞𝐜𝐢𝐟𝐢𝐜 𝐑𝐞𝐪𝐮𝐢𝐫𝐞𝐦𝐞𝐧𝐭? 𝐀𝐬𝐤 𝐭𝐨 𝐎𝐮𝐫 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐄𝐱𝐩𝐞𝐫𝐭 : https://www.alliedmarketresearch.com/purchase-enquiry/10826

𝐁𝐲 𝐑𝐞𝐠𝐢𝐨𝐧 :
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, Spain, Rest of Europe)
Asia-Pacific (Japan, China, India, Australia, South Korea, Rest of Asia-Pacific)
LAMEA (Latin America, Middle East and Africa)

𝐂𝐨𝐯𝐢𝐝-19 𝐬𝐜𝐞𝐧𝐚𝐫𝐢𝐨:

The Covid-19 outbreak disrupted the workflow in the healthcare sector. The pandemic resulted in a reduction in the number of beds in the neurorehabilitation units that allow patients and doctors to work in intensive care and deal with Covid-19 patients.
In-patient neurorehabilitation has been limited to only patients with post-acute disabilities and degenerative diseases.

𝐍𝐞𝐮𝐫𝐨𝐫𝐞𝐡𝐚𝐛𝐢𝐥𝐢𝐭𝐚𝐭𝐢𝐨𝐧 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧
The global neurorehabilitation market is segmented on the basis of type, application, end user, and region. By type, it is segmented into neuro-robotic devices, non-invasive stimulators, and brain-computer interfaces. By application, it is segmented into brain stroke, Parkinson's disease, multiple sclerosis, spinal cord injury, traumatic brain injury, cerebral palsy, and others. By end user, it is categorized into rehabilitation centers, hospitals, and clinics. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

𝐒𝐞𝐠𝐦𝐞𝐧𝐭 𝐑𝐞𝐯𝐢𝐞𝐰
By type, the non-destructive segment has the largest share in 2020, accounting for almost half of the global neurorehabilitation market. Furthermore, the segment is estimated to register the highest CAGR of 8.77% during the forecast period, due to the advancement of technology and increased demand for non-invasive procedures. The report includes research on other areas such as neuro-robotic devices and brain-computer interfaces.

Depending on the application, it is divided into stroke, Parkinson's disease, multiple sclerosis, spinal cord injury, traumatic brain injury, cerebral palsy and others. The stroke segment dominated the global neurorehabilitation market in 2020 and is expected to continue this trend during the forecast period. This is due to the increasing prevalence of stroke worldwide.

𝐅𝐑𝐄𝐐𝐔𝐄𝐍𝐓𝐋𝐘 𝐀𝐒𝐊𝐄𝐃 𝐐𝐔𝐄𝐒𝐓𝐈𝐎𝐍𝐒?
Q1. What is the total market value of Neurorehabilitation market report ?
Q2. What would be forecast period in the market report?
Q3. What is the market value of Neurorehabilitation market in 2021?
Q4. Which is base year calculated in the Neurorehabilitation market report?
Q5. Which are the top companies hold the market share in Neurorehabilitation market ?
Q6. Which is the most influencing segment growing in the Neurorehabilitation market report?
Q7. What are the key trends in the Neurorehabilitation market report?
Q8. What are the market values / growth % of emerging countries?
Q9. What is Neurorehabilitation?
Q10. What are Neurorehabilitation market products used for?

𝐑𝐞𝐥𝐚𝐭𝐞𝐝 𝐑𝐞𝐩𝐨𝐫𝐭𝐬:

>Insulin Syringes Market https://www.alliedmarketresearch.com/insulin-syringes-market

>Antinuclear Antibody Test Market https://www.alliedmarketresearch.com/antinuclear-antibody-test-market

>Single Cell Analysis Market https://www.alliedmarketresearch.com/single-cell-analysis-market-A06188

>Biohazard Bags Market https://www.alliedmarketresearch.com/biohazard-bags-market-A07949

>Ankylosing spondylitis market https://www.alliedmarketresearch.com/ankylosing-spondylitis-market-A10266

𝐁𝐔𝐘 𝐍𝐎𝐖 : https://www.alliedmarketresearch.com/checkout-final/80becb146a10ed0d495a35c77b3b0e16

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions". AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free):
+1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975

This release was published on openPR.